User profiles for Ariel Graff-Guerrero

Ariel Graff

Professor
Verified email at camh.ca
Cited by 12379

Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology

…, BY Glenthøj, A Graff-Guerrero… - American Journal of …, 2017 - Am Psychiatric Assoc
Objective: Research and clinical translation in schizophrenia is limited by inconsistent
definitions of treatment resistance and response. To address this issue, the authors evaluated …

[HTML][HTML] Individual determinants of COVID-19 vaccine hesitancy

…, EE Brown, B Agic, BG Pollock, A Graff-Guerrero - PloS one, 2021 - journals.plos.org
Background Novel coronavirus disease 2019 (COVID-19) vaccine hesitancy is a barrier to
achieving herd immunity, and thus, a prominent public health concern. This study aimed to …

[HTML][HTML] Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis

…, J Ramírez-Bermúdez, A Graff-Guerrero - …, 2011 - nature.com
The glutamatergic and dopaminergic systems are thought to be involved in the pathophysiology
of schizophrenia. Their interaction has been widely documented and may have a role in …

Cerebral blood flow associated with creative performance: a comparative study

RA Chávez-Eakle, A Graff-Guerrero, JC García-Reyna… - Neuroimage, 2007 - Elsevier
Creativity is important for social survival and individual wellbeing; science, art, philosophy
and technology have been enriched and expanded by this trait. To our knowledge this is the …

[HTML][HTML] Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy …

…, T Miyazaki, T Kishimoto, A Graff-Guerrero… - Molecular …, 2019 - nature.com
Alterations in glutamatergic neurotransmission are implicated in the pathophysiology of
depression, and the glutamatergic system represents a treatment target for depression. To …

Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making

G Fervaha, A Graff-Guerrero, KK Zakzanis… - Journal of psychiatric …, 2013 - Elsevier
Background Motivational impairments are a core feature of schizophrenia and although
there are numerous reports studying this feature using clinical rating scales, objective …

Kynurenine pathway in depression: A systematic review and meta-analysis

…, T Miyazaki, H Uchida, A Graff-Guerrero… - Neuroscience & …, 2018 - Elsevier
Abnormalities of the kynurenine (KYN) pathway may be implicated in the pathophysiology
of depression. However, the relationships between depression and each metabolite of the …

Kynurenic acid in schizophrenia: a systematic review and meta-analysis

…, G Remington, A Graff-Guerrero - Schizophrenia …, 2017 - academic.oup.com
Kynurenic acid (KYNA) is an endogenous antagonist of N-methyl-D-aspartate and α7 nicotinic
acetylcholine receptors that is derived from astrocytes as part of the kynurenine pathway …

Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies

…, H Uchida, M Mimura, A Graff-Guerrero… - Molecular …, 2022 - nature.com
Background The glutamate (Glu) and gamma aminobutyric acid (GABA) hypotheses of
schizophrenia were proposed in the 1980s. However, current findings on those metabolite levels …

The potential role of dopamine D3 receptor neurotransmission in cognition

…, B Mulsant, B Pollock, A Graff-Guerrero - European …, 2013 - Elsevier
Currently available treatments have limited pro-cognitive effects for neuropsychiatric
disorders, such as schizophrenia, Parkinson's disease and Alzheimer's disease. The primary …